i. History of allergy to (components of) the BCG vaccine or serious adverse events to prior BCG administration <br/ >ii. Any signs or symptoms of COVID-19 within the past 24 hours <br/ >iii. Pregnancy or planning pregnancy <br/ >iv. Breastfeeding <br/ >v. Suspicion of active viral or bacterial infection <br/ >vi. Any Immunocompromised subjects including <br/ >o Human immunodeficiency virus (HIV-1), <br/ >o Neutropenic with less than 1500 neutrophils/mm3, <br/ >o Solid organ or bone marrow transplantation, <br/ >o Chemotherapy or radiotherapy, and <br/ >o Primary immunodeficiency <br/ >vii. Subject on immunosuppressed or taking immunosuppressive drugs <br/ >viii. Documented history of COVID-19 infection <br/ >ix. Active malignancy within the prior two years <br/ >o Active skin disease such as eczema, dermatitis or psoriasis at or near site of vaccination <br/ >o Direct involvement in the design or the execution of the study <br/ >o Not willing to give consent <br/ >

i. History of allergy to (components of) the BCG vaccine or serious adverse events to prior BCG administration <br/ >ii. Any signs or symptoms of COVID-19 within the past 24 hours <br/ >iii. Pregnancy or planning pregnancy <br/ >iv. Breastfeeding <br/ >v. Suspicion of active viral or bacterial infection <br/ >vi. Any Immunocompromised subjects including <br/ >o Human immunodeficiency virus (HIV-1), <br/ >o Neutropenic with less than 1500 neutrophils/mm3, <br/ >o Solid organ or bone marrow transplantation, <br/ >o Chemotherapy or radiotherapy, and <br/ >o Primary immunodeficiency <br/ >vii. Subject on immunosuppressed or taking immunosuppressive drugs <br/ >viii. Documented history of COVID-19 infection <br/ >ix. Active malignancy within the prior two years <br/ >o Active skin disease such as eczema, dermatitis or psoriasis at or near site of vaccination <br/ >o Direct involvement in the design or the execution of the study <br/ >o Not willing to give consent <br/ >

N/A

N/A

i. History of allergy to (components of) the BCG vaccine or serious adverse events to prior BCG administration <br/ >ii. Any signs or symptoms of COVID-19 within the past 24 hours <br/ >iii. Pregnancy or planning pregnancy <br/ >iv. Breastfeeding <br/ >v. Suspicion of active viral or bacterial infection <br/ >vi. Any Immunocompromised subjects including <br/ >o Human immunodeficiency virus (HIV-1), <br/ >o Neutropenic with less than 1500 neutrophils/mm3, <br/ >o Solid organ or bone marrow transplantation, <br/ >o Chemotherapy or radiotherapy, and <br/ >o Primary immunodeficiency <br/ >vii. Subject on immunosuppressed or taking immunosuppressive drugs <br/ >viii. Documented history of COVID-19 infection <br/ >ix. Active malignancy within the prior two years <br/ >o Active skin disease such as eczema, dermatitis or psoriasis at or near site of vaccination <br/ >o Direct involvement in the design or the execution of the study <br/ >o Not willing to give consent <br/ >

i. History of allergy to (components of) the BCG vaccine or serious adverse events to prior BCG administration <br/ >ii. Any signs or symptoms of COVID-19 within the past 24 hours <br/ >iii. Pregnancy or planning pregnancy <br/ >iv. Breastfeeding <br/ >v. Suspicion of active viral or bacterial infection <br/ >vi. Any Immunocompromised subjects including <br/ >o Human immunodeficiency virus (HIV-1), <br/ >o Neutropenic with less than 1500 neutrophils/mm3, <br/ >o Solid organ or bone marrow transplantation, <br/ >o Chemotherapy or radiotherapy, and <br/ >o Primary immunodeficiency <br/ >vii. Subject on immunosuppressed or taking immunosuppressive drugs <br/ >viii. Documented history of COVID-19 infection <br/ >ix. Active malignancy within the prior two years <br/ >o Active skin disease such as eczema, dermatitis or psoriasis at or near site of vaccination <br/ >o Direct involvement in the design or the execution of the study <br/ >o Not willing to give consent <br/ >